Related Experiment Video

Updated: Aug 16, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

[Recent progress in oncogene studies]

K Toyoshima

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |June 1, 1987
    PubMed

    Insights

    Cancer research is exploring oncogenes, which are linked to cell growth regulation. Understanding proto-oncogene functions is key to analyzing normal and malignant cell growth mechanisms.

    Area of Science:

    • Oncology and molecular biology research.
    • Cancer genetics and cell signaling.

    Background:

    • The study of oncogenes has gained prominence in cancer research.
    • Viral oncogenes have cellular counterparts.
    • Proto-oncogenes may play a role in cancer initiation and progression through mutations or altered expression.

    Purpose of the Study:

    • To investigate the role of oncogenes in cancer.
    • To understand the normal functions of proto-oncogene products.
    • To facilitate the biochemical analysis of normal and malignant cell growth.

    Main Methods:

    • Identification of cellular counterparts of viral oncogenes.
    • Analysis of point-mutations and altered expression of proto-oncogenes.
    • Biochemical analysis of proto-oncogene products (e.g., growth factors, receptors).

    Main Results:

    • Oncogene studies are a significant area of cancer research.
    • Proto-oncogenes are implicated in cancer development.
    • Understanding proto-oncogene functions is crucial for deciphering cell growth mechanisms.

    Conclusions:

    • Elucidating proto-oncogene functions is essential for understanding cancer.
    • This knowledge aids in the biochemical analysis of normal and malignant cell growth.
    • Oncogene research provides insights into cancer initiation and progression.

    More Related Videos

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

    Published on: April 11, 2025

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...